Squadron Capital LLC filed a Form 4 with the U.S. Securities and Exchange Commission on September 11, 2026, disclosing the sale of 302,369 shares of OrthoPediatrics Corp common stock on September 10, 2026.

Key Highlights

  • Shares sold: 302,369 shares of OrthoPediatrics Corp common stock were disposed of on September 10, 2026.
  • Weighted average price: $21.01 per share, with individual transactions ranging from $21.00 to $21.69, inclusive.
  • Remaining ownership: Squadron Capital LLC beneficially owned 6,201,764 shares following the reported transaction.
  • Stated reason: According to the filing, the sale "was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses."
  • Reporting persons: Two entities filed jointly - Squadron Capital LLC and Squadron Capital Holdings LLC, which the filing identifies as the controlling member of Squadron Capital LLC.
  • Relationship to issuer: Both reporting persons are identified as 10% owners in the filing.

Squadron Capital LLC Reduces OrthoPediatrics Position in September 2026 Sale

According to the Form 4 filed on September 11, 2026, Squadron Capital LLC, a Granby, Connecticut-based entity, sold 302,369 shares of NASDAQ:KIDS common stock on September 10, 2026. The filing reports a weighted average sale price of $21.01, and notes that the shares "were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive." The filing further states that Squadron Capital LLC undertakes to provide full information regarding the number of shares sold at each separate price upon request.

Following the transaction, Squadron Capital LLC directly held 6,201,764 shares of OrthoPediatrics Corp common stock, according to the filing. The filing identifies Squadron Capital Holdings LLC, headquartered at 104 S. Michigan Ave., Chicago, Illinois 60603, as the controlling member of Squadron Capital LLC. Both entities are listed as reporting persons and both are characterized as 10% owners in relation to OrthoPediatrics Corp.

The filing was signed by David R. Pelizzon, identified as President of Squadron Capital LLC, and Mary Falcon, identified as Manager of Squadron Capital Holdings LLC, both on September 11, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

Squadron Capital LLC reported the September 10, 2026 sale of 302,369 OrthoPediatrics Corp shares at a weighted average price of $21.01, leaving the entity with 6,201,764 shares directly held. The filing cited capital needs for other portfolio businesses as the stated reason for the sale.